The Fuchs Case: Can Secrecy in Science Work?

Today much information has recently become available, including U.S. Atomic Energy Commission files and FBI files on Fuchs' statements and on his and Gold's confessions, as well as memoirs published by Fuchs' communist associates in England. From these and other sources it is clear that many aspects of the case were kept from the public in order to conceal important political secrets, not just atomic ones. One political secret was how Fuchs' spying was discovered in the first place. We now kno

Written byRobert Chadwell Williams
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

One political secret was how Fuchs' spying was discovered in the first place. We now know that in 1949, when American government cryptographers decoded some messages sent from the Soviet embassy in New York to Moscow during World War II, they came upon a report by Fuchs on work being done at Los Alamos. To conceal from the Soviet Union that their codes had been deciphered, the American and British security services sought to have Fuchs confess to his actions. The result was the series of interviews with Skardon and Perrin. The breaking of Soviet codes was never mentioned during the prosecution of the case and remained a government secret for decades.

Another political secret was that Fuchs was known to be a communist even before he arrived in England as a refugee from Nazi Germany in 1933. From a Gestapo report and from information provided by a German agent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies